Cite
MLA Citation
J. Zhou et al.. “Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses.” Clinical oncology, vol. 34, no. 7, 2022, pp. e316–e317. http://access.bl.uk/ark:/81055/vdc_100156685990.0x00002b